![Markus J. Cappel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus J. Cappel
Presidente presso
OSE IMMUNOTHERAPEUTICS
Profilo
Markus J.
Cappel currently works at OSE Immunotherapeutics SA, as Chairman from 2025.
Dr. Cappel also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Business Development, Alkermes, Inc., as Vice President-Business Development from 1998 to 2001, Cygnus, Inc., as Principal, and ChemoCentryx, Inc., as Treasurer & Chief Business Officer from 2007 to 2022.
Dr. Cappel received his undergraduate degree and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and Masters Business Admin degree from Harvard Business School.
Posizioni attive di Markus J. Cappel
| Società | Posizione | Inizio |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Presidente | 30/09/2025 |
Precedenti posizioni note di Markus J. Cappel
| Società | Posizione | Fine |
|---|---|---|
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 18/10/2011 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Corporate Officer/Principal | 01/01/2001 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Formazione di Markus J. Cappel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
40
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
